Fractional Flow Reserve Devices Market Size to grow by USD 1167.4 million between 2024-2028
According to a research report “ Fractional Flow Reserve Devices Market” by Product (FFR guidewires, FFR monitoring systems) Application (Single-vessel diseases, Multi-vessel diseases) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 1167.4 million, at a CAGR of over 20.08% during the forecast period. The global prevalence of Cardiovascular Diseases (CVDs), including stable angina, unstable angina, and sudden cardiac deaths, is on the rise, accounting for an estimated 17.9 million annual fatalities worldwide. In the US alone, the CDC reports that heart diseases claimed approximately 697,000 lives in 2020. Annually, around 10 million Americans experience angina, with over 450,000 new cases emerging. In the US healthcare system, an estimated 300,000 to 500,000 new cases of stable angina are diagnosed yearly. Nearly one million hospitalizations in the US each year are due to a primary diagnosis of unstable angina. The annual incidence rate of unstable angina in industrialized nations hovers around 60 cases per 100,000 individuals in the general population.
Browse market data tables, figures, and in-depth TOC on “Fractional Flow Reserve Devices Market” by Product (FFR guidewires, FFR monitoring systems) Application (Single-vessel diseases, Multi-vessel diseases) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Product, the FFR guidewires segment is projected to dominate the market size in 2024
Single-vessel disease refers to a condition where the small arteries in the heart, specifically those supplying one coronary artery, exhibit impaired function. This impairment reduces the delivery of oxygen-rich blood to the heart, leading to symptoms such as angina and shortness of breath. Despite the presence of symptoms indicative of heart disease, this condition may go undetected due to insufficient narrowing in the heart's main arteries. Women and individuals with diabetes or hypertension are more susceptible to developing single-vessel disease. Early detection and treatment are crucial to mitigate the potential complications and improve patient outcomes. Fractional Flow Reserve (FFR) devices play a significant role in the diagnosis and treatment of single-vessel disease by assessing the functional significance of coronary artery stenosis and guiding interventional strategies. These devices provide valuable information to healthcare professionals, enabling them to make informed decisions and optimize treatment plans for patients.
By Application, Single-vessel diseases segment is expected to hold the largest market size for the year 2024
In the Fractional Flow Reserve (FFR) devices market, advanced diagnostic tools are utilized to assess the physiological significance of coronary artery stenoses. FFR measurement involves the deployment of a 0.014-inch pressure wire, equipped with a pressure sensor, to determine the pressure distal to a stenosis, across an intermediate lesion, with the aid of a guiding catheter in the target artery. Leading vendors in the market provide pressure wires that can function as guidewires. The market offers various guidewire technologies, which can be categorized into three types: pressure wire technology (piezoelectric wires), microcatheter technology (optical fiber catheters), and optical fiber technology (optical fiber wires). Pressure wire technology incorporates a 0.014-inch wire with a distal pressure sensor integrated into the junction of the radiopaque and radiolucent sections. These specialized wires facilitate the precise measurement of FFR values.
North America is forecasted to hold the largest market size by region in 2024
The Fractional Flow Reserve (FFR) devices market represents a significant growth opportunity for medical technology companies. FFR technology, which measures blood flow in coronary arteries to assess the need for revascularization, is becoming increasingly adopted for diagnosing and treating ischemic heart disease. Market growth is driven by rising prevalence of cardiovascular diseases, advancements in FFR technology, and expanding application areas. Key players in the market include Abbott Laboratories, Philips Healthcare, and Medtronic.
The Fractional Flow Reserve Devices Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Fractional Flow Reserve (FFR) devices market is witnessing significant growth due to the increasing prevalence of heart-related diseases, including coronary artery diseases (CAD) and cardiovascular diseases (CVD), caused by unhealthy lifestyle choices such as high blood cholesterol, smoking, and hypertension. Eating habits play a crucial role in the development of these conditions, especially in the aging population. FFR devices are used during angioplasty procedures to measure the pressure difference between a stenosed epicardial coronary artery and the distal bed, indicating the presence of induce ischemia. This information helps surgeons make informed decisions, reducing mortality rates and improving patient outcomes. Traditional angiography methods have limitations in assessing the functional significance of coronary artery stenosis. The rising geriatric population and the increasing awareness of the benefits of FFR technology are expected to drive the growth of the FFR devices market. Healthcare experts predict that the market will continue to expand, providing innovative solutions for the diagnosis and treatment of CAD and CVD.
Market Research Overview
The Fractional Flow Reserve (FFR) devices market is witnessing significant growth due to the increasing prevalence of heart-related diseases, such as high blood cholesterol, induced by fast-food chains and unhealthy eating habits. According to the World Health Organization, cardiovascular ailments, including multi-vessel diseases and single-vessel diseases, are the leading cause of mortality worldwide. Surgeons and cardiologists are increasingly relying on FFR monitoring systems to assess the severity of stenosis in the epicardial coronary artery and determine the need for angioplasty or aortocoronary bypass grafts. FFR devices use pressure guidewires to measure the pressure difference between a stenosed and non-stenosed segment of the coronary artery, providing valuable information for the diagnosis and treatment of coronary artery diseases, including serial stenosis, left main stenoses, and Myocardial ischemia. The FFR devices market includes both invasive monitoring segment using catheters and non-invasive monitoring segment using wire-based systems. FFR guidewires are particularly useful in tortuous vessels and complex anatomies. Lifestyle factors such as high BMI, physical inactivity, hypertension, smoking, and diabetes, including Type II diabetes, are major contributors to the rising prevalence of heart disease. The geriatric population, with its increased susceptibility to cardiovascular diseases (CVD), is another significant market driver. Traditional angiography, with its associated mortality rates, is being increasingly replaced by FFR monitoring systems. Key players in the FFR devices market include Medtronic, Abbott Laboratories, and Boston Scientific.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
